Your Medical Device Prototype Works. Now Try Making 10,000 of Them.
Prototype vs Production: 9 Things That Change When a Medical Device Goes to Manufacturing
The prototype is sitting on the table.
It works.
The enclosure fits. The mechanism performs as expected. The electronics are inside. The team has demonstrated it to clinicians, investors or internal stakeholders.
After months of development, it finally feels like a product.
Then someone asks:
“How do we make 10,000 of these?”
That one question can send a product that looked almost finished back to the engineering table.
Not because the prototype failed.
Because making one working device and manufacturing thousands of consistent devices are two very different problems.
At Inspire Design, across 60+ healthcare product development projects, we have seen this transition change the conversation around materials, components, tolerances, assembly, suppliers, tooling and cost.
A prototype asks: Can we make this work?
Production asks: Can we make it work repeatedly?
Let's follow what happens when the same device moves from one world to the other.
1. “It Works” Becomes “Will Every Unit Work?”
Our prototype works.
Perhaps the team has built three or four of them.
Each has been assembled by someone who knows the design intimately. If something doesn't fit perfectly, the engineer understands where to adjust it.
That flexibility starts disappearing in production.
If 1,000 devices are being manufactured, unit #784 cannot depend on the engineer who designed the product being there to make an adjustment.
Dimensions need to be defined.
Tolerances matter.
Processes need to be repeatable.
Assembly needs to be understood.
Specifications need to communicate what the designer intended.
This isn't just a manufacturing preference. FDA's design-transfer guidance describes the objective of production specifications as enabling devices to be produced repeatedly and reliably within product and process capabilities.
That is one of the biggest shifts from medical device prototype to production.
The prototype proves the possibility.
Production demands repeatability.
2. The 3D-Printed Enclosure Suddenly Needs Another Look
Let's say our prototype has a 3D-printed enclosure.
It has worked perfectly through several iterations.
The team changed the CAD, printed another enclosure and tested it. If something needed another 2 mm of clearance, it was relatively easy to change.
Now assume the expected production volume makes injection moulding an appropriate manufacturing option.
The same enclosure needs to be looked at differently.
Wall thickness becomes important.
Draft needs consideration.
Parting lines enter the discussion.
Undercuts may affect tooling.
Ribs and bosses need to work with the intended process.
Material selection may change.
The product can eventually look almost identical to the prototype while the engineering underneath it has changed considerably.
This is where Design for Manufacturing (DFM) starts earning its place in product development.
The question is no longer only:
“Does this geometry work?”
It becomes:
“Does this geometry work for the way we intend to manufacture it?”
3. Twelve Parts Look Very Different When You Need 120,000 of Them
Consider a simple example.
Our prototype contains 12 manufactured components.
For one prototype, that doesn't necessarily feel excessive.
Now manufacture 10,000 devices.
Those 12 components become as many as 120,000 individual parts moving through procurement, manufacturing and assembly.
This is an illustrative example, but it shows why a design team begins looking at the product differently once volume enters the conversation.
Can two components become one?
Does a separate bracket really need to exist?
Can a fastener be eliminated?
Could one feature be incorporated into an existing moulded component?
Does simplifying the assembly introduce any new performance or risk concerns?
The objective isn't simply to reduce the number of parts.
It is to remove unnecessary complexity without compromising what the device needs to do.
A component that barely gets noticed in Prototype #2 can become a significant manufacturing decision at 10,000 units.
4. ₹50 Doesn't Look Like Much Until You Multiply It by 10,000
Here's another simple example.
Assume one design decision adds ₹50 to the cost of every manufactured device.
For a prototype, ₹50 is almost irrelevant.
For 10 prototypes, it is ₹500.
At 10,000 units, it becomes ₹5 lakh.
Again, these numbers are illustrative rather than a cost estimate for medical-device production.
But the multiplication is important.
Manufacturing forces teams to reconsider decisions that seemed insignificant during prototyping.
A material.
A fastener.
An additional machining operation.
A complicated assembly.
An unnecessarily tight tolerance.
An extra component.
This doesn't mean the objective should be to make every medical device as cheaply as possible. Performance, user needs, quality, safety and applicable requirements cannot simply be traded away for a lower component cost.
It means understanding what each design decision becomes at scale.
There is evidence for thinking about this early. Manufacturing research has reported that at least 70% of the cost of a manufactured part can be decided at the design stage, which is why design is such an important point for considering manufacturing economics.
By the time thousands of units are being produced, many of the influential decisions have already been made.
5. “We Can Assemble It” Becomes “How Do We Assemble It 1,000 Times?”
Our prototype has been assembled successfully.
But perhaps it took an engineer 45 minutes.
Maybe they had to hold two components in a particular position while inserting a screw.
Perhaps a cable had to be moved slightly to close the enclosure.
For one prototype, this is manageable.
Now put the same process on a production floor.
Suddenly we need to understand:
How many assembly steps are there?
Can the product be assembled in the wrong orientation?
Are fasteners easily accessible?
Does the operator need a fixture?
Can a cable be trapped during assembly?
Is inspection possible after the enclosure closes?
Could two components be designed to locate themselves more naturally?
This is where Design for Assembly (DFA) becomes part of the conversation.
A prototype asks whether we can assemble the product.
Production asks whether people can assemble it consistently and practically, again and again.
That is a much higher bar.
6. The Prototype Material May Not Be the Production Material
During prototyping, material is often selected around the question being tested.
A 3D-printed polymer might be perfectly adequate for checking form and fit.
A different prototype might use a material chosen to evaluate a mechanism.
That doesn't automatically make either one the right production material.
Once manufacturing enters the discussion, material selection has to account for the actual device requirements and intended manufacturing process.
Performance matters.
So can dimensional stability, surface requirements, cleaning or sterilisation needs where relevant, availability, manufacturing compatibility and other product-specific considerations.
FDA's design-input material identifies factors including physical characteristics, safety, biocompatibility where applicable, intended use, manufacturing processes and use environment among considerations that may need to be addressed during medical-device design.
The prototype material helped us learn.
The production material has a different job: it has to meet the requirements of the finished product and its intended application.
7. Your CAD File Now Has to Work Without You in the Room
This change is easy to underestimate.
During development, the designer and engineer carry enormous amounts of information in their heads.
They know why a feature exists.
They know which dimension is critical.
They know where some variation is acceptable and where it isn't.
A supplier doesn't automatically know any of that.
Neither does a contract manufacturer.
The design therefore has to become something that can be communicated and reproduced.
That may involve drawings, specifications, tolerances, material definitions, assembly instructions, inspection requirements, digital manufacturing data, fixtures and other production information appropriate to the device and process.
FDA's design-transfer guidance specifically identifies examples such as assembly drawings, component procurement specifications, manufacturing instructions, inspection and test specifications, digital data files, moulds and manufacturing aids as ways production information may be communicated.
There is a simple way we think about this:
If the supplier has to call the designer every time a part is made, the design probably hasn't finished communicating yet.
Moving from prototype to production means transferring knowledge, not just transferring CAD.
8. Testing One Product Becomes Controlling a Process
Our prototype has passed its tests.
That is important.
But manufacturing introduces another question:
A manufacturing process introduces variation.
Components come from suppliers.
Parts are assembled by different people or equipment.
Materials can vary within specified limits.
Machines and tooling operate repeatedly.
This is why production requires attention not only to whether the design works, but whether the manufacturing process can reproduce it consistently.
FDA makes this distinction clearly: once a design has been established, the adequacy of the manufacturing process affects whether that design can be consistently reproduced without degrading its inherent quality.
For applicable processes, this can mean defined manufacturing controls, inspection, acceptance activities and process validation.
In the U.S., FDA's current Quality Management System Regulation (QMSR) requires manufacturers to establish and follow a quality management system so products consistently meet applicable requirements and specifications.
The regulatory requirements will, of course, depend on the device and market.
But the engineering principle is universal:
A good product design needs a manufacturing process capable of reproducing it.
9. The Product May Look the Same. Almost Everything Behind It Has Changed.
Put the original prototype beside the eventual production device.
To a clinician, they may look remarkably similar.
Same overall form.
Same grip.
Same interface.
Same basic function.
But underneath, a lot may have changed.
A 3D-printed enclosure has become a moulded component.
Three parts have become two.
A fastener has disappeared.
Tolerances have been reconsidered.
The assembly sequence has changed.
The material has changed.
Suppliers now have defined specifications.
Inspection requirements exist.
Manufacturing processes have been established.
None of that necessarily changes the idea that made the prototype exciting in the first place.
It makes the idea repeatable.
And this is why we don't see manufacturing as something that begins after product development is over.
For medical devices, design transfer itself is part of the development journey. FDA guidance notes that design transfer may begin before final validation stages and continue as design and development evolves, allowing production-related corrections to happen during the process rather than only at the end.
For us, that's the important lesson.
Don't finish designing the prototype and then start thinking about manufacturing.
Let manufacturing thinking improve the design while there is still time to change it.
Prototype vs Production: What Actually Changes?
Here is the simplest way to look at it.
Prototype | Production |
Can we make 1? | Can we make 1,000+ consistently?* |
Easy to modify between builds | Changes become more controlled |
3D printing/rapid fabrication may be appropriate | Production process must suit the product and volume |
Often assembled by development team | Repeatable assembly process required |
Individual part cost may matter less | Unit economics become increasingly important |
Designer knows how everything works | Specifications must communicate that knowledge |
Prototype material may be sufficient for learning | Production material must meet finished-device requirements |
Individual testing | Production controls and consistent acceptance become important |
Proof that the concept works | Evidence that the product can be reproduced |
*1,000 is illustrative. Appropriate manufacturing volumes vary significantly by product.
The Most Expensive Prototype May Be the One You Have to Redesign After You Thought You Were Finished
This is the part of medical device development that is easy to underestimate.
The prototype works.
Everyone approves it.
The team starts talking to manufacturers.
And only then:
The moulding supplier says the enclosure needs changing.
Assembly reveals that two parts are unnecessarily difficult to fit together.
A tolerance that worked on individually made prototypes becomes difficult to maintain consistently.
The intended production material behaves differently.
A component becomes unexpectedly expensive at scale.
None of these automatically means the prototype was badly designed.
They show why manufacturing considerations need to enter the product-development conversation before everyone considers the design finished.
There is a cost implication too. Research across manufacturing/product development has repeatedly found that a large share of eventual product cost is influenced during design; one manufacturing study puts that figure at at least 70%.
This is where DFM can create value.
Not by making a finished product cheaper at the last minute.
By making manufacturing part of the design conversation while meaningful choices can still be made.
Put Your Medical Device Prototype Through the 1 → 1,000 Test
If you have a working prototype today, ask your team a different question:
What would have to change if we had to manufacture 1,000 of these?
Then look at these 9 areas:
1. Process: Do we know how each major component would actually be manufactured?
2. Parts: Are there components that could potentially be eliminated or consolidated?
3. Materials: Have we identified appropriate production materials?
4. Tolerances: Do we know which dimensions are genuinely critical?
5. Assembly: Can the product be assembled repeatedly without relying on the designer?
6. Suppliers: Can the selected manufacturing partners achieve the required
specifications consistently?
7. Economics: Do we understand the major drivers of unit cost?
8. Quality: How will we know that each manufactured device meets its defined requirements?
9. Scale: Which parts of the prototype need redesign before increasing production volume?
You may have good answers to all nine.
You may discover three questions nobody has discussed yet.
Either result is useful.
Because finding those questions while the product is still being developed gives you more room to solve them.
A Working Prototype Is a Milestone. It Isn't the Finish Line.
Getting a medical device prototype to work is a significant achievement.
But there is another stage of engineering between:
“We built it.”
and
“We can manufacture it.”
Across 60+ healthcare product development projects, this is one of the transitions we pay particular attention to at Inspire Design.
Because decisions around product design, engineering, prototyping and manufacturing don't live in separate boxes. A manufacturing constraint can change the engineering. An engineering change can affect assembly. A material decision can affect the manufacturing process.
The earlier those conversations happen, the more options the development team usually has.
Have a Working Medical Device Prototype?
If the product works but you're now asking “How do we manufacture this?”, that is exactly the stage where a design and engineering review can be useful.
At Inspire Design, we support clinicians, healthcare startups and medical-device companies across product design, engineering, prototyping and Design for Manufacturing.
You don't necessarily need another prototype.
You may need to understand what has to change before the prototype becomes a production-ready design.
Have a prototype on your desk? Show us what you've built. We can start there.
FAQs: Taking a Medical Device From Prototype to Production
1. How do you take a medical device from prototype to production?
Moving a medical device from prototype to production typically requires reviewing the design for the intended manufacturing process, materials, tolerances, assembly, suppliers, quality requirements and production specifications. The exact process depends on the device, intended market, manufacturing method and applicable regulatory requirements.
2. Is a working medical device prototype ready for manufacturing?
Not necessarily. A working prototype can demonstrate that a concept or design functions, while manufacturing requires the product to be produced consistently and according to defined requirements.
3. What is Design for Manufacturing in medical devices?
Design for Manufacturing (DFM) involves developing or refining a product with the intended manufacturing processes and constraints in mind. Depending on the device, this can include materials, component geometry, tolerances, tooling, assembly, production volumes and cost.
3. When should DFM begin?
Manufacturing considerations are most useful when they can still influence product design. They do not necessarily need to wait until prototyping has finished. FDA's design-transfer material similarly recognises that transfer towards production can begin while design and development are still evolving.
4. What is the difference between a prototype and a production device?
A prototype is generally built to answer development questions or demonstrate aspects of a design. A production device must be manufactured repeatedly according to defined requirements using controlled production processes appropriate to the product.
5. Does a 3D-printed medical device prototype need to be redesigned for manufacturing?
Sometimes. It depends on whether additive manufacturing is also the intended production process. FDA notes that additive manufacturing itself is used commercially in medical devices and has cleared more than 100 devices made using additive technologies. If another production process is intended, such as moulding or machining, aspects of the design may need to change accordingly.
6. What should be reviewed before scaling medical device production?
The review can include the intended manufacturing process, materials, tolerances, component count, assembly, suppliers, inspection/testing requirements, applicable quality/regulatory requirements and production economics.
Comments